切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - Proteasome - Peptidoglycan synthesis - Calcium-Activated Potassium (KCa) Channels

24件产品中的 1-10

页面
每页
清除全部
  1. VR23
    B6026 VR23
    Target: Proteasome
    Summary: 蛋白酶抑制剂
      ≥45.55 mg/mL
      insoluble in H2O
  2. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  3. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  4. Dequalinium Chloride
    B2191 Dequalinium Chloride
    中文名: 地喹氯铵
    Target: PKC|Calcium-Activated Potassium (KCa) Channels
    Summary: PKC抑制剂
      insoluble in DMSO
      insoluble in H2O
  5. Cefoselis Sulfate
    B1906 Cefoselis Sulfate
    中文名: 硫酸头孢噻利
    Target: Peptidoglycan synthesis
    Summary: β-内酰胺抗生素
      ≥62.1 mg/mL
      ≥2.3 mg/mL
  6. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  7. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  8. PYR-41
    B1492 PYR-41
     2 Citation
    Target: Proteasome
    Summary: 泛素活化酶(E1)抑制剂
      ≥18.55 mg/mL
      insoluble in H2O
  9. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  10. Zonisamide
    A5354 Zonisamide
    中文名: 唑尼沙胺
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) Channels
    Summary: 抗惊厥和机械效应的抗癫痫药
      ≥8.35 mg/mL
      insoluble in H2O

24件产品中的 1-10

页面
每页